Journal article

Momentary assessment technology as a tool to help patients with depression help themselves

M Wichers, CJP Simons, IMA Kramer, JA Hartmann, C Lothmann, I Myin-Germeys, AL van Bemmel, F Peeters, Ph Delespaul, J van Os

Acta Psychiatrica Scandinavica | WILEY | Published : 2011


OBJECTIVE: Given high relapse rates and residual symptoms in depression, new strategies to increase treatment effectiveness are required. A promising avenue is to investigate how electronic momentary assessment technology may contribute to clinical assessment and interventions in depression. METHOD: A literature search was conducted focusing on the potential contribution of momentary assessments to clinical applications in depression. RESULTS: Momentary assessments are able to reveal subtle, small but repetitive and relevant patterns of emotional expression that predict future course of depression. A momentary assessment tool may expose manageable pieces of daily life behaviour contributing ..

View full abstract


Funding Acknowledgements

PsyMate development was made possible in part by unrestricted grants from Servier and Janssen-Cilag.PsyMate is developed under the auspices of the Maastricht University technology transfer office; none of the authors will benefit financially. Dr F. Peeters received speakers' fees from GlaxoSmithKline, Wyeth, Astra Zeneca, Lundbeck, Eli Lilly, Servier and Janssen-Cilag. Jim van Os is/has been an unrestricted research grant holder with or has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Lundbeck, Organon, Janssen-Cilag, GSK, AstraZeneca, Pfizer and Servier, companies that have an interest in the treatment of mental health disorders. Dr Ph. Delespaul received speaker's fees from Lundbeck and Janssen-Cilag. Prof. Inez Myin-Germeys received speaker's fees from Janssen-Cilag and Bristol-Myers Squibb. Dr M Wichers, Dr CJP Simons, IMA Kramer, JA Hartmann, C Lothmann and Dr AL van Bemmel had no financial interests.